S G Revankar
- PhaeohyphomycosisSanjay G Revankar
Division of Infectious Diseases, Wayne State University, Harper University Hospital, Detroit, MI 48201, USA
Infect Dis Clin North Am 20:609-20. 2006..Much additional work is needed to better understand the pathogenic mechanisms underlying phaeohyphomycosis and optimize therapy for these often refractory infections...
- Dematiaceous fungiSanjay G Revankar
Dallas VA Medical Center, Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA
Semin Respir Crit Care Med 25:183-9. 2004..Further studies are needed to better understand the pathogenesis and treatment of these uncommon infections...
- Therapy of infections caused by dematiaceous fungiSanjay G Revankar
Dallas VA Medical Center, 4500 S Lancaster Road, Dallas, TX 75216, USA
Expert Rev Anti Infect Ther 3:601-12. 2005..Azoles such as itraconazole and voriconazole have the most consistent in vitro activity, although newer agents may also play a role in therapy in the future...
- Disseminated phaeohyphomycosis: review of an emerging mycosisSanjay G Revankar
Dallas Veterans Administration Medical Center and Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75216, USA
Clin Infect Dis 34:467-76. 2002..The development of newer antifungal agents and combination therapy may hold promise in improving the management of these devastating infections in the future...
- Clinical implications of mycotoxins and StachybotrysSanjay G Revankar
Dallas Veterans Affairs Medical Center, Texas, USA
Am J Med Sci 325:262-74. 2003..Rigorously controlled studies are needed to clarify these issues...
- Primary central nervous system phaeohyphomycosis: a review of 101 casesSanjay G Revankar
Dallas Veterans Affairs Medical Center, University of Texas Southwestern Medical Center, Dallas, Texas 75216, USA
Clin Infect Dis 38:206-16. 2004..Complete excision of brain lesions may provide better results than simple aspiration. An aggressive medical and surgical approach is warranted in treating these infections to optimize outcomes...
- Fluconazole versus Candida albicans: a complex relationshipJ R Graybill
Division of Infectious Diseases, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284, USA
Antimicrob Agents Chemother 42:2938-42. 1998..albicans isolates is associated with increasing fluconazole MICs in some cases but not in others and shows that these low-virulence strains may not consistently cause infection...
- Metarrhizium anisopliae as a cause of sinusitis in immunocompetent hostsS G Revankar
University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
J Clin Microbiol 37:195-8. 1999..Itraconazole and newer azole compounds were more active. Metarrhizium species may cause disease in humans, even those without evidence of immunosuppression, and are apparently highly resistant to amphotericin B in vitro...
- In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetesS Narreddy
Department of Medicine, Division of Infectious Diseases, Wayne State University, Detroit, MI, USA
J Antimicrob Chemother 65:701-3. 2010..Our aim was to study the in vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes...
- Occurrence of candiduria in a population of chronically catheterized patients with spinal cord injuryL L Goetz
Spinal Cord Injury Service, Veterans Affairs North Texas Health Care System, 4500 S Lancaster Rd, SCI 128, Dallas, TX 75216, USA
Spinal Cord 48:51-4. 2010..Prospective data collection...
- Cure of disseminated zygomycosis with cerebral involvement using high dose liposomal amphotericin B and surgerySanjay G Revankar
Wayne State University, Harper University Hospital, Detroit, Michigan 48201, USA
Med Mycol 45:183-5. 2007..Since penetration of the central nervous system by amphotericin B is poor the application of high dose therapy may be useful in cases of cerebral zygomycosis...
- Dematiaceous fungiSanjay G Revankar
Division of Infectious Diseases, Department of Medicine, University of Texas Southwestern Medical Center and Dallas Veterans Affairs Medical Center, Dallas, TX, USA
Mycoses 50:91-101. 2007..Further studies are needed to better understand the pathogenesis and optimal treatment of these uncommon infections...
- Echinocandins--first-choice or first-line therapy for invasive candidiasis?Jack D Sobel
N Engl J Med 356:2525-6. 2007
- Use of terbinafine in rare and refractory mycosesSanjay G Revankar
Wayne State University, Division of Infectious Diseases, Harper University Hospital, 3990 John R St, 5 Hudson Detroit, MI 48201, USA
Future Microbiol 3:9-17. 2008..We review the current literature with regard to in vitro data and clinical experience with terbinafine in the treatment of rare and refractory mycoses...
- Nosocomial outbreak of Exophiala jeanselmei fungemia associated with contamination of hospital waterMarcio Nucci
Mycology Laboratory, Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, 21941 590 Rio de Janeiro, Brazil
Clin Infect Dis 34:1475-80. 2002..RAPD typing showed that isolates from case patients and isolates from the pharmacy water were highly related, whereas the patterns of isolates recovered from the 2 other sources of water were distinct...
- Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal lineagKerry O'Donnell
National Center for Agricultural Utilization Research, U S Department of Agriculture, Peoria, IL 61604 3999, USA
J Clin Microbiol 42:5109-20. 2004..S. hospitals, providing support for the hypothesis that hospitals may serve as a reservoir for nosocomial fusarial infections...